Ben Stecher et al: Research into Parkinson’s Disease needs reform

As Parkinson’s Disease (PD) patients and research advocates, we remain hopeful that the whirlwind of research and translational studies which flood the pages of journals around the world will result in treatments that significantly improve quality of life for people with PD within our lifetime. While the Parkinson’s community continues to wait, however, we must […]

Read More…

Rob Hendry: Gross negligence manslaughter does not exist in Scotland—is it time to move English law towards the Scottish position?

Recent high profile cases against doctors have brought the offence of gross negligence manslaughter (GNM) into sharp focus and created an unprecedented level of debate and fear across the profession. In Scotland the offence does not exist—so what is the comparable offence in Scotland and is it better suited to determining the culpability of a […]

Read More…

Nazrul Islam: The international medical community must act to help Rohingya refugees in Bangladesh

The forced displacement of the Rohingya population has a historical root since the late 1970s. Approximately 200,000 Rohingya were displaced to neighbouring Bangladesh in 1978, and about 260,000 in 1991-92. [1]  The recent displacement of 400,000-420,000 Rohingya, of which about 240,000 were children, made it by far the largest displacement of Rohingya population. [2] The […]

Read More…

Diana Anderson: There remains a fundamental gap between the aims of hospital design and the final user experience

Matt Morgan wrote previously about the impact that poor hospital design has on staff, patients, and healthcare. It is a timely debate and hit home for me as I am both a physician and an architect. When I was a resident doctor, a large part of my hesitation in pursuing advanced training as a doctor […]

Read More…

Jeffrey Aronson: When I Use a Word . . . Carnitine

Last week I discussed meldonium, which was banned by the World Anti-Doping Agency (WADA) in January 2016 for use by sportsmen and women, because it supposedly increases blood flow and therefore exercise capacity. Meldonium is the International Nonproprietary Name (INN) of 3-(2,2,2-trimethyldiazaniumyl)propanoate, an analogue of the immediate precursor of carnitine, trimethylaminobutyrate (Figure 1). Meldonium is […]

Read More…

Theodora Bloom and Navjoyt Ladher: Diversity in clinical research and scholarly publishing

It’s International Women’s Day, so we’re all being challenged to think about how far we’ve managed to eliminate gender biases in our work. What’s going on in sexism and diversity for academic research and scholarly publishing? At a rallying talk for editors of BMJ’s journals (Twitter #bmjeds) this morning, Pavel Ovseiko from Oxford’s Radcliffe Department […]

Read More…